Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie, Man Chu, Gendi Song, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 303-318
Closed Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

A bioinformatics analysis, pre-clinical and clinical conception of autophagy in pancreatic cancer: Complexity and simplicity in crosstalk
Milad Ashrafizadeh, Wei Zhang, Rongjun Zou, et al.
Pharmacological Research (2023) Vol. 194, pp. 106822-106822
Open Access | Times Cited: 63
Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
Emine Bayraktar, Recep Bayraktar, Hülya Öztatlıcı, et al.
Non-Coding RNA (2023) Vol. 9, Iss. 2, pp. 27-27
Open Access | Times Cited: 53
Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
Mehrdad Hashemi, Motahare Sadat Ayat Mirdamadi, Yasmin Talebi, et al.
Pharmacological Research (2022) Vol. 187, pp. 106568-106568
Open Access | Times Cited: 65
O-GlcNAcylation in cancer development and immunotherapy
Xue-Fen He, Xiaoli Hu, Gao-Jing Wen, et al.
Cancer Letters (2023) Vol. 566, pp. 216258-216258
Closed Access | Times Cited: 35
Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis
Yuan Chi, Xin He, Zhaoyu Liu
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy
Sepideh Mirzaei, Mohammad Gholami, Hui Li Ang, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3348-3348
Open Access | Times Cited: 42
LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer
Zhengwei Song, Xiaoguang Wang, Fei Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 33
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy
Weijia Wang, Wenjun Liu, Qiuli Chen, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 84-97
Closed Access | Times Cited: 28
Tumor Cell Derived Lnc‐FSD2‐31:1 Contributes to Cancer‐Associated Fibroblasts Activation in Pancreatic Ductal Adenocarcinoma Progression through Extracellular Vesicles Cargo MiR‐4736
Xinglong Geng, Le Li, Yan Luo, et al.
Advanced Science (2023) Vol. 10, Iss. 10
Open Access | Times Cited: 20
Recent advances in curcumin-loaded biomimetic nanomedicines for targeted therapies
Fenting Lei, Pei Li, Tangting Chen, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 80, pp. 104200-104200
Closed Access | Times Cited: 15
Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies
Hannah Hisham Rashwan, Ayman Taher, H. A. Hassan, et al.
Pathology - Research and Practice (2024) Vol. 256, pp. 155223-155223
Closed Access | Times Cited: 6
Exploring the therapeutic potential of quercetin in cancer treatment: Targeting long non-coding RNAs
Farhad Sheikhnia, Ahmad Fazilat, Vahid Rashidi, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155374-155374
Closed Access | Times Cited: 6
GAS5 lncRNA: A biomarker and therapeutic target in breast cancer
Lakshmi Thangavelu, Ehssan Moglad, Gaurav Gupta, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155424-155424
Closed Access | Times Cited: 5
A Cathode-Anode Ratiometric Internal Standard Electrochemiluminescence Recognition Strategy Based on Hexagonal AgNCs and ZnCdSe QDs Dual-Labeled Exon Conservative Motif Aggregation for LncRNA Assay
Zhong Jia, Qiguo Yang, Bin Wang, et al.
Analytical Chemistry (2025)
Closed Access
MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
Luis Alberto Bravo-Vázquez, Natalia Frías-Reid, Ana Gabriela Ramos-Delgado, et al.
Translational Oncology (2022) Vol. 27, pp. 101579-101579
Open Access | Times Cited: 22
Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
Milad Ashrafizadeh, Kuo Luo, Wei Zhang, et al.
Environmental Research (2023) Vol. 240, pp. 117443-117443
Closed Access | Times Cited: 14
ETS2 promotes cardiomyocyte apoptosis and autophagy in heart failure by regulating lncRNA TUG1/miR‐129‐5p/ATG7 axis
Tan Li, Di Xiong, Hui Zhang, et al.
The FASEB Journal (2023) Vol. 37, Iss. 6
Closed Access | Times Cited: 13
Modulating MGMT expression through interfering with cell signaling pathways
Peiying Bai, Tengjiao Fan, Xin Wang, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115726-115726
Closed Access | Times Cited: 13
M6A-modified lncRNA FAM83H-AS1 promotes colorectal cancer progression through PTBP1
Xiaojing Luo, Yun‐Xin Lu, Yun Wang, et al.
Cancer Letters (2024) Vol. 598, pp. 217085-217085
Open Access | Times Cited: 4
The Role of microRNA in Pancreatic Cancer
Beata Smolarz, Adam Durczyński, Hanna Romanowicz, et al.
Biomedicines (2021) Vol. 9, Iss. 10, pp. 1322-1322
Open Access | Times Cited: 28
Nutri-Epigenetic Effects of Phenolic Compounds from Extra Virgin Olive Oil: A Systematic Review
Andrea del Saz‐Lara, María‐Carmen López de las Hazas, Francesco Visioli, et al.
Advances in Nutrition (2022) Vol. 13, Iss. 5, pp. 2039-2060
Open Access | Times Cited: 21
The roles of lncRNAs and miRNAs in pancreatic cancer: a focus on cancer development and progression and their roles as potential biomarkers
Somayeh Jafari, Hossein Motedayyen, Parisa Javadi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Regulation of main ncRNAs by polyphenols: A novel anticancer therapeutic approach
Liang Zhang, Qingzheng Kang, Mengxiao Kang, et al.
Phytomedicine (2023) Vol. 120, pp. 155072-155072
Open Access | Times Cited: 9
Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma
Jieyu He, Lin Ling, Zhongyue Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top